AAAAAA
Results: 1-25/56
Authors:
Gross, DJ
Weiss, L
Reibstein, I
Hedlund, G
Dahlen, E
Rapoport, MJ
Slavin, S
Citation: Dj. Gross et al., The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus, INT IMMUNO, 1(6), 2001, pp. 1131-1139
Authors:
Morecki, S
Yacovlev, E
Gelfand, Y
Uzi, I
Slavin, S
Citation: S. Morecki et al., Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma, J IMMUNOTH, 24(2), 2001, pp. 114-121
Authors:
Slavin, S
Nagler, A
Shapira, M
Panigrahi, S
Samuel, S
Or, A
Citation: S. Slavin et al., Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases, CR R ONC H, 39(1-2), 2001, pp. 25-29
Authors:
Slavin, S
Citation: S. Slavin, Recreational use of amyl nitrite, VENEREOLOGY, 14(2), 2001, pp. 81-82
Authors:
Ball, LJ
Lambell, NJ
Ormerod, TC
Slavin, S
Mariani, JA
Citation: Lj. Ball et al., Representing design rationale to support innovative design reuse: a minimalist approach, AUTO CONSTR, 10(6), 2001, pp. 663-674
Authors:
Slavin, S
Or, R
Aker, M
Shapira, MY
Panigrahi, S
Symeonidis, A
Cividalli, G
Nagler, A
Citation: S. Slavin et al., Nonmyeloablative stem cell transplantation for the treatment of cancer andlife-threatening nonmalignant disorders: past accomplishments and future goals, CANC CHEMOT, 48, 2001, pp. S79-S84
Authors:
Burt, RK
Barr, W
Oyama, Y
Traynor, A
Slavin, S
Citation: Rk. Burt et al., Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis, J RHEUMATOL, 28, 2001, pp. 42-48
Authors:
Nagler, A
Aker, M
Or, R
Naparstek, E
Varadi, G
Brautbar, C
Slavin, S
Citation: A. Nagler et al., Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation, EXP HEMATOL, 29(3), 2001, pp. 362-370
Authors:
Slavin, S
Ackerstein, A
Morecki, S
Gelfand, Y
Cividalli, G
Citation: S. Slavin et al., Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes, BONE MAR TR, 28(8), 2001, pp. 795-798
Authors:
Morecki, S
Gelfand, Y
Nagler, A
Or, R
Naparstek, E
Varadi, G
Engelhard, D
Akerstein, A
Slavin, S
Citation: S. Morecki et al., Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen, BONE MAR TR, 28(3), 2001, pp. 243-249
Authors:
Panigrahi, S
Nagler, A
Or, R
Wolf, DG
Slavin, S
Shapira, MY
Citation: S. Panigrahi et al., Indolent aspergillus arthritis complicating fludarabine-based non-myeloablative stem cell transplantation, BONE MAR TR, 27(6), 2001, pp. 659-661
Authors:
Slavin, S
Nagler, A
Panigrahi, S
Varadi, G
Ackerstein, A
Samuel, S
Or, R
Citation: S. Slavin et al., Shifting towards better immunotherapy rather than more intensive chemoradiotherapy using a non-myeloablative approach in patients with leukemia, HEMAT BLOOD, 40, 2001, pp. 674-677
Authors:
Morecki, S
Slavin, S
Citation: S. Morecki et S. Slavin, Toward amplification of a graft-versus-leukemia effect while minimizing graft-versus-host disease, J HEMATH ST, 9(3), 2000, pp. 355-366
Authors:
Leshem, B
Vourka-Karussis, U
Slavin, S
Citation: B. Leshem et al., Correlation between enhancement of graft-versus-leukemia effects followingallogeneic bone marrow transplantation by rIL-2 and increased frequency ofcytotoxic T-lymphocyte precursors in murine myeloid leukemia, CYTOK CELL, 6(3), 2000, pp. 141-147
Authors:
Hiller, C
Wittmann, S
Slavin, S
Fickenscher, H
Citation: C. Hiller et al., Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector, GENE THER, 7(8), 2000, pp. 664-674
Authors:
Slavin, S
Citation: S. Slavin, New strategies for bone marrow transplantation, CURR OP IM, 12(5), 2000, pp. 542-551
Authors:
Levy, J
Amar, A
Brautbar, C
Slavin, S
Kapelushnik, J
Citation: J. Levy et al., Transient recovery of endogenous immune function following haploidentical peripheral stem cell transplantation in a patient with severe combined immunodeficiency without evidence of engraftment, ACT PAEDIAT, 89(2), 2000, pp. 248-250
Authors:
Carella, AM
Giralt, S
Slavin, S
Citation: Am. Carella et al., Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia, HAEMATOLOG, 85(3), 2000, pp. 304-313
Authors:
Morecki, S
Yacovlev, E
Gelfand, Y
Trembovler, V
Shohami, E
Slavin, S
Citation: S. Morecki et al., Induction of antitumor immunity by indomethacin, CANCER IMMU, 48(11), 2000, pp. 613-620
Authors:
Nagler, A
Or, R
Naparstek, E
Varadi, G
Slavin, S
Citation: A. Nagler et al., Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation, EXP HEMATOL, 28(9), 2000, pp. 1096-1104
Authors:
Slavin, S
Nagler, A
Varadi, G
Or, R
Citation: S. Slavin et al., Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis, EXP HEMATOL, 28(7), 2000, pp. 853-857
Authors:
Nagler, A
Ackerstein, A
Or, R
Naparstek, E
Slavin, S
Citation: A. Nagler et al., Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation, EXP HEMATOL, 28(11), 2000, pp. 1225-1231
Authors:
Ilan, Y
Nagler, A
Zeira, E
Adler, R
Slavin, S
Shouval, D
Citation: Y. Ilan et al., Maintenance of immune memory to the hepatitis B envelope protein followingadoptive transfer of immunity in bone marrow transplant recipients, BONE MAR TR, 26(6), 2000, pp. 633-638
Authors:
Carella, AM
Champlin, R
Slavin, S
McSweeney, P
Storb, R
Citation: Am. Carella et al., Mini-allografts: ongoing trials in humans, BONE MAR TR, 25(4), 2000, pp. 345-350
Authors:
Slavin, S
Or, R
Prighozina, T
Gurevitch, O
Aker, M
Panighari, S
Shapira, M
Nagler, A
Citation: S. Slavin et al., Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man, BONE MAR TR, 25, 2000, pp. S54-S57